Advisor Group Holdings, Inc. In Med Pharmaceuticals Inc. Transaction History
Advisor Group Holdings, Inc.
- $42.2 Billion
- Q3 2024
A detailed history of Advisor Group Holdings, Inc. transactions in In Med Pharmaceuticals Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 27 shares of INM stock, worth $117. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27
Previous 32
15.63%
Holding current value
$117
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding INM
# of Institutions
16Shares Held
1.14MCall Options Held
0Put Options Held
0-
Advisor Shares Investments LLC Bethesda, MD733KShares$3.2 Million0.03% of portfolio
-
Ubs Group Ag212KShares$926,6100.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il56.7KShares$247,6300.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny50.3KShares$219,7930.0% of portfolio
-
Hrt Financial LP New York, NY38.4KShares$167,6720.0% of portfolio
About InMed Pharmaceuticals Inc.
- Ticker INM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 908,761
- Market Cap $3.97M
- Description
- InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in precl...